MedTrace Logo

Evaluation of Reactive Oxygen Metabolites in the Value of COPD

NCT02297633 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 320

Last updated 2014-11-21

No results posted yet for this study

Summary

This study through the long-term observation followed up for 2 years to find the change of the COPD patients blood ROMs, systematically evaluate the relationship between ROMs and the severity of COPD. Evaluate the differences of prognosis between the different oxidative stress level (according to the level of ROMs are divided into higher and normal phenotype). Explore the new oxidative stress evaluation index ROMs application value in COPD.

Conditions

  • COPD(Chronic Obstructive Pulmonary Disease)

Sponsors & Collaborators

  • Beijing Chao Yang Hospital

    lead OTHER

Principal Investigators

  • Ting Yang, Doctor · Respiratory Institute, Beijing chaoyang hospital

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2017-05-31
Completion
2017-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02297633 on ClinicalTrials.gov